Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Hi all
Been reading this message board and watching the falling share price over the last few months. Having bought in at a lower price initially and topped up at a higher price, I find myself at more or less break even (shame I didn't sell at a good profit in the mid 20p's but hey ho!)
Been thinking about topping up but so often when I do a dummy purchase I notice the price has edged down a little more! It feels like trying to catch a very sharp falling knife! There will be a bottom just don't know where it is - lets face it, if we could predict that we'd all be millionaires!
I remain optimistic for Scancell and the trials and confident that we will (eventually!) hear positive news and see a material uplift in the share price. My own personal view is to hold what I have - if it goes down to 8p over the next few weeks I will top up. If the SP takes off and I miss out then so be it - I'll still be in profit.
Sorry for the ramblings - think it helps putting it in black and white rather than swirling around in my head!
I’d suggest we’re all surprised but news has to appear at some point…
Just for interest, I haven’t “waited ten years” and I won’t be “waiting another ten years” either. I invested in 2020, shortly before Redmile, and have a similar average cost (albeit without the convertible carry).
I’m surprised that the market seems to be underwhelmed by the opportunity here…..but have little doubt that can be corrected very quickly indeed.
Lofas,
If in you opinion, the share price is going to nothing then why don't you sell up? Yet you say you'll continue to hold? Great logic right there!
Brad Loncar , has started his tour of the uk Biotech
He is an astute man . Imagine it’s well researched and he is interested to hear what Lindy has to say ? As we all are .
See below GSK ( results were out today )
TOP VIDEO: GSK's Emma Walmsley on the company's pipeline, business development, AI, UK life sciences, and more | 04/30/24
https://www.biotechtv.com
11/13 if that was significant the share price would reflect that and not be on its way to nothing.
It's been about 22 weeks since the last update.
When 13 had had there 1st scan. Can't be long until another update.
Derisory? Well in their opinion. 11/13 excellent but not statistically significant otherwise TO would have happened already. If you want to invest and wait another 10 years filled with posters and yesterdays new, be my guest.
What would Vulpes say about a share price that is half the share price that, 12 months ago, they called derisory?
What if the reason for lack of news is a bid for the whole company?
What price would Vulpes and Redmile be content to sell at? None of us know. But my guess would be a big multiple of the current share price. An agreed deal at around 60p is not an impossibility, given sector precedent and valuations.
So we know that 11 out of 13 patients on SCOPE trial have had a positive response. I would say those patients have had very good news from Scancell!!!
Try harder Lofas.
Thanks,
IMO, it is not a great price for newbies. Personally I will not add one cent to what I have, as I mentioned before I hope patients gets good news from the one of the big players in the field, I doubt it will come from SC , if it does ….great.
"It is a great price for newbies though"
Why is it? The SP has fallen from every single "great price" called out on these boards - from 33p and down. Was 5p a great price 12 years ago? Not if you have held - doubling your money in 12 years is not an exceptionally good return. Of course, if you bought at 5p 12 years ago and sold in the 30p+ range (where it sat for three years) it was a good buy.
I stand corrected Lofas, apologies. It is hugely frustrating for us LTH's I agree, however just in my opinion, in the grand scheme of things whether the price is 9p, 10p, 11p, 12p, even 15p is somewhat irrelevant.
It is a great price for newbies though, which is no comfort for us LTH's though.
I’d say 20.02 is a bit early to be hitting the bottle - or discussion boards.
If there is a BOD, they are FAST asleep!!!!!
Obviously, you are very happy , lots of reasons to be, not point to be upset, what good it will bring, wrote off this investment not selling and equally not adding more.
Do I get the impression that lofas is not happy?
Lofas you don’t know what is going on inside Scancell. There may be some very high level discussions going on that hinge on the quality of the trial data due in 3 to 4 months time,
The market is not the truth it’s just sentiment in a vacuum.
I hoped that at least one new deal would have been confirmed by now but I don’t know what is happening or if anyone is seriously evaluating either AvidiMab or one of our GlyMab’s.
It’s just guess work at best. I would like to believe that the trials are building solid data that cannot be ignored. I would hope that both our Mab platforms are being well received and proving they do what it says on the tin.
So as I said before it’s up to us to decide if we hold on or take a hit and move on.
I’m holding on because everything trial wise is so far, looking very positive.
Not adding any more even at 0.1p, abysmal company shameful management , hope for good results for patient all be it not from this poke in the eye company.
No I was not lucky enough to do that. I’m £18K down on this pos.
"Spoke to soon " Saturday , Its only Tuesday and they are indeed cheaper.
Under 9p today .
Oh the irony in your 18:46 Lofas.
@lofas - I take you sold up a while back and are looking for a cheaper buy in?
8 soon. Buying at 11P proved to be throwing good money after bad.
No posts as there is nothing to say. Better this way rather than trying to follow the pile of nonsense coming out from LTH.